Accessibility Menu
 
Cann Group logo

Cann Group

(ASX) CAN

Current Price$0.01
Market Cap$9.58M
Since IPO (2017)-99%
5 Year-99%
1 Year-74%
1 Month-14%

Cann Group Financials at a Glance

Market Cap

$9.58M

Revenue (TTM)

$26.81M

Net Income (TTM)

$32.87M

EPS (TTM)

$0.01

P/E Ratio

0.52

Dividend

$0.00

Beta (Volatility)

0.17 (Low)

Price

$0.01

Volume

3,448,822

Open

$0.01

Previous Close

$0.01

Daily Range

$0.01 - $0.01

52-Week Range

$0.01 - $0.03

CAN News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cann Group

Industry

Pharmaceuticals

CEO

Jennifer Lee Pilcher

Headquarters

Port Melbourne, VIC 3207, AU

CAN Financials

Key Financial Metrics (TTM)

Gross Margin

-21%

Operating Margin

-97%

Net Income Margin

1%

Return on Equity

73%

Return on Capital

-32%

Return on Assets

27%

Earnings Yield

1.92%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$9.58M

Shares Outstanding

1.60B

Volume

3.45M

Short Interest

0.00%

Avg. Volume

5.12M

Financials (TTM)

Gross Profit

$5.15M

Operating Income

$8.94M

EBITDA

$8.94M

Operating Cash Flow

$9.64M

Capital Expenditure

$157.00K

Free Cash Flow

$9.80M

Cash & ST Invst.

$10.00K

Total Debt

$75.84M

Cann Group Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$4.52M

-46.7%

Gross Profit

$4.46M

+51.8%

Gross Margin

-98.63%

N/A

Market Cap

$9.58M

N/A

Market Cap/Employee

$239.52K

N/A

Employees

40

N/A

Net Income

$26.38M

+284.0%

EBITDA

$2.49M

+61.1%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$14.15M

+77.8%

Accounts Receivable

$868.00K

-74.0%

Inventory

$6.48M

-47.7%

Long Term Debt

$157.00K

N/A

Short Term Debt

$14.95M

-77.1%

Return on Assets

26.52%

N/A

Return on Invested Capital

-31.90%

N/A

Free Cash Flow

$115.00K

+98.6%

Operating Cash Flow

$11.00K

+99.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BGT.AXBio-Gene Technology Limited
$0.03+3.13%
VBS.AXVectus Biosystems Limited
$0.15+0.00%
ICR.AXIntelicare Holdings Limited
$0.03+8.70%
IRX.AXInhaleRx Limited
$0.03+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$43.23+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.77+0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$77.45-0.04%
CYCNCyclerion Therapeutics
$6.38+3.12%

Questions About CAN

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.